iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Sun Pharma gets import alert for Halol facility

9 Dec 2022 , 09:18 AM

Sun Pharma

Sun Pharmaceutical Industries Limited had earlier announced regarding the USFDA inspection at the Company’s Halol (Gujarat) facility from April 26 to May 9, 2022.

The Company has received a communication from the USFDA stating that the facility has been listed under Import Alert. The Import Alert implies, that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until the facility becomes compliant with cGMP standards.

The USFDA has excluded 14 products from this Import Alert subject to certain conditions.

For the year ended March 31, 2022, supplies to the US market from the Halol facility accounted for approximately 3% of the Company’s consolidated revenues, including the 14 excluded products as mentioned above.

The Company continues to cooperate with the USFDA and will undertake all necessary steps to resolve these issues and to ensure that the regulator is completely satisfied with the Company’s remedial action.

Sun Pharma remains committed to being cGMP compliant and in supplying high-quality products to its customers and patients globally.

At around 9:18 AM, Sun Pharmaceuticals Industries Ltd is currently trading at Rs985 per share up by Rs4.05 or 0.41% from its previous closing of Rs980.95 per share on the BSE.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Halol facility
  • Sun Pharmaceuticals Industries
  • Sun Pharmaceuticals Industries Ltd
  • Sun Pharmaceuticals Industries Ltd announcements
  • Sun Pharmaceuticals Industries Ltd launch
  • Sun Pharmaceuticals Industries Ltd news
  • Sun Pharmaceuticals Industries Ltd shares
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.